// App-Quantinova.ai

AB0511 : INTERNATIONAL CONSENSUS ON ANCA TESTING AND INTERPRETATION BEYOND SYSTEMIC VASCULITIS

Researchers

Presenter

  • S. Moiseev

Principal Investigators

  • Y. Arimura

  • D. Bogdanos

  • C. Elena

  • J. Damoiseaux

  • M. Ferrante

  • L. F. Flores-Surez

  • M. Fritzler

  • P. Invernizzi

  • D. Jayne

  • J. C. Jennette

  • M. Little

  • S. P. Mcadoo

  • P. Novikov

  • C. D. Pusey

  • A. Radice

  • A. D. Salama

  • J. Savige

  • M. Segelmark

  • Y. Shoenfeld

  • R. A. Sinico

  • M. J. R. De Sousa

  • U. Specks

  • B. Terrier

  • A. Tzioufas

  • S. Vermeire

  • M. H. Zhao

  • X. Bossuyt

Medical Centers

  • I.M. Sechenov First Moscow State Medical University, Moscow, Russia

  • Maastricht University Medical Center, Maastricht, Netherlands

  • The Jikei University School of Medicine, Tokyo, Japan

  • University of Larissa, Larissa, Greece

  • University of Tübingen, Kirchheim-Teck, Germany

  • Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico

  • Universita degli Studi Milano Bicocca, Milano, Italy

  • University of Cambridge, Cambridge, United Kingdom

  • University of North Carolina Hospitals, Chapel Hill, United States of America

  • Trinity Health Kidney Centre, Dublin, Ireland

  • Neurology, San Carlo Borromeo Hospital, Milan, Italy

  • The Royal Marsden Hospital, London, United Kingdom

  • University of Melbourne, Melbourne, Australia

  • Lund University Hospital, Lund, Sweden

  • Lund University Hospital, Lund, Sweden

  • Centro de Medicina Laboratorial Germano de Sousa, Lisbon, Portugal

  • Mayo Clinic - Rochester - United States of America

  • Hopital Cochin, Paris, France

  • National and Kapodistrian University of Athens, Athens, Greece

  • Peking University People's Hospital, Beijing, China

Locations

  • Russia

  • Canada

  • Netherlands

  • Japan

  • Greece

  • Germany

  • Belgium

  • Mexico

  • Italy

  • United Kingdom

  • United States

  • Ireland

  • Australia

  • Sweden

  • Israel

  • Portugal

  • France

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A